Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M HAUGE

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Frontiers in Endocrinology|October 26, 2023
Disturbed bone marrow adiposity in patients with Cushing's syndrome and glucocorticoid- and postmenopausal- induced osteoporosisNina N Sørensen, Christina M Andreasen, Pia R Jensen, et al.
Seminars in Arthritis and Rheumatism|July 29, 2025
Impact of a rapid access strategy on referral rates, diagnosis, and glucocorticoid initiation in suspected polymyalgia rheumaticaElisabeth L Nielsen, Andreas W Nielsen, Agnete O Donskov, et al.
Scandinavian Journal of Rheumatology|February 6, 2023
Disease activity-guided tapering of biologics in patients with inflammatory arthritis: a pragmatic, randomized, open-label, equivalence trialL Uhrenholt, R Christensen, L Dreyer, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|February 23, 2026
Large Vessel Vasculitis Primarily Affecting the Lower Extremities: A Case Series and Literature ReviewJohanne H Egedal, André H Dias, Pieter H Nienhuis, et al.
Scandinavian Journal of Rheumatology|August 24, 2017
Local bone loss in patients with anti-citrullinated peptide antibody and arthralgia, evaluated with high-resolution peripheral quantitative computed tomographyK K Keller, J S Thomsen, K Stengaard-Pedersen, et al.
Scandinavian Journal of Rheumatology|September 28, 2018
Smoking and response to rituximab in rheumatoid arthritis: results from an international European collaborationK Chatzidionysiou, G Lukina, C Gabay, et al.
Cell Chemical Biology|December 4, 2025
Targeted inhibition of mu-opioid receptors in neuronal subpopulations by membrane-tethered Naloxo-DART antagonistsJ Sanchez, A Bonifazi, S Groom, et al.
RMD Open|February 2, 2026
Sex and anticitrullinated protein antibodies modify the relationship between inflammation and cardiovascular risk in rheumatoid arthritisGeorge A Karpouzas, Virginia Pascual-Ramos, Miguel A Gonzalez-Gay, et al.
RMD Open|June 24, 2026
Rheumatoid factor and anticitrullinated protein antibody status jointly influence the association between disease activity and cardiovascular risk in rheumatoid arthritisGeorge A Karpouzas, Miguel A Gonzalez-Gay, Virginia Pascual-Ramos, et al.
The New England Journal of Medicine|April 2, 2025
A Phase 3 Trial of Upadacitinib for Giant-Cell ArteritisDaniel Blockmans, Sara K Penn, Arathi R Setty, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Frontiers in Endocrinology|October 26, 2023
Disturbed bone marrow adiposity in patients with Cushing's syndrome and glucocorticoid- and postmenopausal- induced osteoporosisNina N Sørensen, Christina M Andreasen, Pia R Jensen, et al.
Seminars in Arthritis and Rheumatism|July 29, 2025
Impact of a rapid access strategy on referral rates, diagnosis, and glucocorticoid initiation in suspected polymyalgia rheumaticaElisabeth L Nielsen, Andreas W Nielsen, Agnete O Donskov, et al.
Scandinavian Journal of Rheumatology|February 6, 2023
Disease activity-guided tapering of biologics in patients with inflammatory arthritis: a pragmatic, randomized, open-label, equivalence trialL Uhrenholt, R Christensen, L Dreyer, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|February 23, 2026
Large Vessel Vasculitis Primarily Affecting the Lower Extremities: A Case Series and Literature ReviewJohanne H Egedal, André H Dias, Pieter H Nienhuis, et al.
Scandinavian Journal of Rheumatology|August 24, 2017
Local bone loss in patients with anti-citrullinated peptide antibody and arthralgia, evaluated with high-resolution peripheral quantitative computed tomographyK K Keller, J S Thomsen, K Stengaard-Pedersen, et al.
Scandinavian Journal of Rheumatology|September 28, 2018
Smoking and response to rituximab in rheumatoid arthritis: results from an international European collaborationK Chatzidionysiou, G Lukina, C Gabay, et al.
Cell Chemical Biology|December 4, 2025
Targeted inhibition of mu-opioid receptors in neuronal subpopulations by membrane-tethered Naloxo-DART antagonistsJ Sanchez, A Bonifazi, S Groom, et al.
RMD Open|February 2, 2026
Sex and anticitrullinated protein antibodies modify the relationship between inflammation and cardiovascular risk in rheumatoid arthritisGeorge A Karpouzas, Virginia Pascual-Ramos, Miguel A Gonzalez-Gay, et al.
RMD Open|June 24, 2026
Rheumatoid factor and anticitrullinated protein antibody status jointly influence the association between disease activity and cardiovascular risk in rheumatoid arthritisGeorge A Karpouzas, Miguel A Gonzalez-Gay, Virginia Pascual-Ramos, et al.
The New England Journal of Medicine|April 2, 2025
A Phase 3 Trial of Upadacitinib for Giant-Cell ArteritisDaniel Blockmans, Sara K Penn, Arathi R Setty, et al.
Pageof 12